BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 11999717)

  • 1. Thyrotropin-releasing hormone-induced down-regulation of pyroglutamyl aminopeptidase II activity involves L-type calcium channels and cam kinase activities in cultures of adenohypophyseal cells.
    Vargas MA; Cisneros M; Joseph-Bravo P; Charli JL
    J Neuroendocrinol; 2002 Mar; 14(3):184-93. PubMed ID: 11999717
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thyrotropin-releasing hormone regulates the diurnal variation of pyroglutamyl aminopeptidase II activity in the male rat adenohypophysis.
    Angel Vargas M; Uribe RM; Cisneros M; Romero F; González S; Joseph-Bravo P; Charli JL
    Eur J Endocrinol; 2002 Sep; 147(3):363-9. PubMed ID: 12213674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thyrotropin-releasing hormone downregulates pyroglutamyl peptidase II activity in adenohypophyseal cells.
    Vargas MA; Joseph-Bravo P; Charli JL
    Neuroendocrinology; 1994 Sep; 60(3):323-30. PubMed ID: 7969791
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid down regulation of pyroglutamyl peptidase II activity by arachidonic acid in primary cultures of adenohypophyseal cells.
    Baeza MA; Ponce G; Joseph-Bravo P; Charli JL
    Life Sci; 2001 Mar; 68(17):2051-60. PubMed ID: 11388706
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of adenohypophyseal pyroglutamyl aminopeptidase II activity by thyrotropin-releasing hormone and phorbol esters.
    Vargas MA; Cisneros M; Joseph-Bravo P; Charli JL
    Endocrine; 2000 Dec; 13(3):267-72. PubMed ID: 11216637
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple hypothalamic factors regulate pyroglutamyl peptidase II in cultures of adenohypophyseal cells: role of the cAMP pathway.
    Vargas MA; Bourdais J; Sanchez S; Uriostegui B; Moreno E; Joseph-Bravo P; Charli JL
    J Neuroendocrinol; 1998 Mar; 10(3):199-206. PubMed ID: 9576608
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anterior pituitary pyroglutamyl peptidase II activity controls TRH-induced prolactin release.
    Cruz R; Vargas MA; Uribe RM; Pascual I; Lazcano I; Yiotakis A; Matziari M; Joseph-Bravo P; Charli JL
    Peptides; 2008 Nov; 29(11):1953-64. PubMed ID: 18703099
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mediobasal hypothalamic and adenohypophyseal TRH-degrading enzyme (PPII) is down-regulated by zinc deficiency.
    Alvarez-Salas E; Alcántara-Alonso V; Matamoros-Trejo G; Vargas MA; Morales-Mulia M; de Gortari P
    Int J Dev Neurosci; 2015 Nov; 46():115-24. PubMed ID: 26315400
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [3-Me-His(2)]-TRH combined with dopamine withdrawal rapidly and transiently increases pyroglutamyl aminopeptidase II activity in primary cultures of adenohypophyseal cells.
    Bourdais J; Romero F; Uriostegui B; Cisneros M; Joseph-Bravo P; Charli JL
    Neuropeptides; 2000 Apr; 34(2):83-8. PubMed ID: 10985924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 3,3',5'-triiodo-L-thyronine reduces efficiency of mRNA knockdown by antisense oligodeoxynucleotides: a study with pyroglutamyl aminopeptidase II in adenohypophysis.
    Cruz R; Chávez-Gutiérrez L; Joseph-Bravo P; Charli JL
    Oligonucleotides; 2004; 14(3):176-90. PubMed ID: 15625913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calcium/calmodulin-dependent protein kinase-II activation in rat pituitary cells in the presence of thyrotropin-releasing hormone and dopamine.
    Cui ZJ; Gorelick FS; Dannies PS
    Endocrinology; 1994 May; 134(5):2245-50. PubMed ID: 8156928
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute administration of alcohol modulates pyroglutamyl amino peptidase II activity and mRNA levels in rat limbic regions.
    de Gortari P; Romero F; Cisneros M; Joseph-Bravo P
    Neurochem Int; 2005 Mar; 46(4):347-56. PubMed ID: 15707699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pyroglutamyl peptidase II inhibition enhances the analeptic effect of thyrotropin-releasing hormone in the rat medial septum.
    Lazcano I; Uribe RM; Martínez-Chávez E; Vargas MA; Matziari M; Joseph-Bravo P; Charli JL
    J Pharmacol Exp Ther; 2012 Jul; 342(1):222-31. PubMed ID: 22532627
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TRH inactivation in the extracellular compartment: role of pyroglutamyl peptidase II.
    Charli JL; Vargas MA; Cisneros M; de Gortari P; Baeza MA; Jasso P; Bourdais J; Peréz L; Uribe RM; Joseph-Bravo P
    Neurobiology (Bp); 1998; 6(1):45-57. PubMed ID: 9713831
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in TRH and its degrading enzyme pyroglutamyl peptidase II, during the development of amygdaloid kindling.
    de Gortari P; Fernández-Guardiola A; Martinez A; Cisneros M; Joseph-Bravo P
    Brain Res; 1995 May; 679(1):144-50. PubMed ID: 7648256
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fasting Enhances Pyroglutamyl Peptidase II Activity in Tanycytes of the Mediobasal Hypothalamus of Male Adult Rats.
    Lazcano I; Cabral A; Uribe RM; Jaimes-Hoy L; Perello M; Joseph-Bravo P; Sánchez-Jaramillo E; Charli JL
    Endocrinology; 2015 Jul; 156(7):2713-23. PubMed ID: 25942072
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic ethanol or glucose consumption alter TRH content and pyroglutamyl aminopeptidase II activity in rat limbic regions.
    de Gortari P; Cisneros M; Joseph-Bravo P
    Regul Pept; 2005 Apr; 127(1-3):141-50. PubMed ID: 15680480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tanycyte pyroglutamyl peptidase II contributes to regulation of the hypothalamic-pituitary-thyroid axis through glial-axonal associations in the median eminence.
    Sánchez E; Vargas MA; Singru PS; Pascual I; Romero F; Fekete C; Charli JL; Lechan RM
    Endocrinology; 2009 May; 150(5):2283-91. PubMed ID: 19179432
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of calcium-calmodulin-dependent protein kinase cascade in thyrotropin (TSH)-releasing hormone induction of TSH and prolactin gene expression.
    Murao K; Imachi H; Cao WM; Yu X; Tokumitsu H; Inuzuka H; Wong NC; Shupnik MA; Kobayashi R; Ishida T
    Endocrinology; 2004 Nov; 145(11):4846-52. PubMed ID: 15308608
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A role for the mitogen-activated protein kinase in mediating the ability of thyrotropin-releasing hormone to stimulate the prolactin promoter.
    Wang YH; Maurer RA
    Mol Endocrinol; 1999 Jul; 13(7):1094-104. PubMed ID: 10406461
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.